<?xml version='1.0' encoding='utf-8'?>
<document id="21192311"><sentence text="Adherence to HIV therapeutic drug monitoring guidelines in The Netherlands." /><sentence text="Therapeutic drug monitoring (TDM) is recommended in several international HIV treatment guidelines" /><sentence text=" The adherence of clinicians to these recommendations is unknown" /><sentence text=" The authors evaluated the adherence to the Dutch TDM guideline of 2005" /><sentence text="" /><sentence text="From the ATHENA cohort study, three scenarios were selected for which the guideline recommended TDM: 1) start of a combination of lopinavir/ritonavir + efavirenz or nevirapine (drug-drug interaction); 2) start of efavirenz (routine TDM); and 3) use of nelfinavir during pregnancy"><entity charOffset="130-139" id="DDI-PubMed.21192311.s6.e0" text="lopinavir" /><entity charOffset="140-149" id="DDI-PubMed.21192311.s6.e1" text="ritonavir" /><entity charOffset="165-175" id="DDI-PubMed.21192311.s6.e2" text="nevirapine" /><entity charOffset="213-222" id="DDI-PubMed.21192311.s6.e3" text="efavirenz" /><entity charOffset="252-262" id="DDI-PubMed.21192311.s6.e4" text="nelfinavir" /><pair ddi="false" e1="DDI-PubMed.21192311.s6.e0" e2="DDI-PubMed.21192311.s6.e0" /><pair ddi="false" e1="DDI-PubMed.21192311.s6.e0" e2="DDI-PubMed.21192311.s6.e1" /><pair ddi="false" e1="DDI-PubMed.21192311.s6.e0" e2="DDI-PubMed.21192311.s6.e2" /><pair ddi="false" e1="DDI-PubMed.21192311.s6.e0" e2="DDI-PubMed.21192311.s6.e3" /><pair ddi="false" e1="DDI-PubMed.21192311.s6.e0" e2="DDI-PubMed.21192311.s6.e4" /><pair ddi="false" e1="DDI-PubMed.21192311.s6.e1" e2="DDI-PubMed.21192311.s6.e1" /><pair ddi="false" e1="DDI-PubMed.21192311.s6.e1" e2="DDI-PubMed.21192311.s6.e2" /><pair ddi="false" e1="DDI-PubMed.21192311.s6.e1" e2="DDI-PubMed.21192311.s6.e3" /><pair ddi="false" e1="DDI-PubMed.21192311.s6.e1" e2="DDI-PubMed.21192311.s6.e4" /><pair ddi="false" e1="DDI-PubMed.21192311.s6.e2" e2="DDI-PubMed.21192311.s6.e2" /><pair ddi="false" e1="DDI-PubMed.21192311.s6.e2" e2="DDI-PubMed.21192311.s6.e3" /><pair ddi="false" e1="DDI-PubMed.21192311.s6.e2" e2="DDI-PubMed.21192311.s6.e4" /><pair ddi="false" e1="DDI-PubMed.21192311.s6.e3" e2="DDI-PubMed.21192311.s6.e3" /><pair ddi="false" e1="DDI-PubMed.21192311.s6.e3" e2="DDI-PubMed.21192311.s6.e4" /></sentence><sentence text=" For each scenario, we determined the proportion of patients for whom TDM was performed" /><sentence text=" Multivariable logistic regression modeling was used to identify determinants for the use of TDM" /><sentence text="" /><sentence text="The adherence to the TDM guideline was 46" /><sentence text="7% in patients who started lopinavir/ritonavir plus efavirenz or nevirapine; 9"><entity charOffset="27-36" id="DDI-PubMed.21192311.s11.e0" text="lopinavir" /><entity charOffset="37-46" id="DDI-PubMed.21192311.s11.e1" text="ritonavir" /><entity charOffset="52-61" id="DDI-PubMed.21192311.s11.e2" text="efavirenz" /><entity charOffset="65-75" id="DDI-PubMed.21192311.s11.e3" text="nevirapine" /><pair ddi="false" e1="DDI-PubMed.21192311.s11.e0" e2="DDI-PubMed.21192311.s11.e0" /><pair ddi="false" e1="DDI-PubMed.21192311.s11.e0" e2="DDI-PubMed.21192311.s11.e1" /><pair ddi="false" e1="DDI-PubMed.21192311.s11.e0" e2="DDI-PubMed.21192311.s11.e2" /><pair ddi="false" e1="DDI-PubMed.21192311.s11.e0" e2="DDI-PubMed.21192311.s11.e3" /><pair ddi="false" e1="DDI-PubMed.21192311.s11.e1" e2="DDI-PubMed.21192311.s11.e1" /><pair ddi="false" e1="DDI-PubMed.21192311.s11.e1" e2="DDI-PubMed.21192311.s11.e2" /><pair ddi="false" e1="DDI-PubMed.21192311.s11.e1" e2="DDI-PubMed.21192311.s11.e3" /><pair ddi="false" e1="DDI-PubMed.21192311.s11.e2" e2="DDI-PubMed.21192311.s11.e2" /><pair ddi="false" e1="DDI-PubMed.21192311.s11.e2" e2="DDI-PubMed.21192311.s11.e3" /></sentence><sentence text="5% for patients who started efavirenz; and 58"><entity charOffset="28-37" id="DDI-PubMed.21192311.s12.e0" text="efavirenz" /></sentence><sentence text="5% for patients who used nelfinavir during pregnancy"><entity charOffset="25-35" id="DDI-PubMed.21192311.s13.e0" text="nelfinavir" /></sentence><sentence text=" Patients treated in clinics that had a TDM assay available locally and patients treated in academic clinics were more likely to receive TDM" /><sentence text=" A higher baseline HIV viral load was another significant predictor for the performing TDM" /><sentence text="" /><sentence text="The adherence of clinicians to the Dutch TDM guidelines varied from low to moderate for the three investigated TDM scenarios" /><sentence text=" This study identifies several determinants for the use of TDM, which may be useful information for those responsible for generating TDM guidelines" /><sentence text="" /></document>